Altimmune, Inc. (ALT)
3.335
+0.22
(+6.89%)
USD |
NASDAQ |
Apr 02, 16:00
3.44
+0.10
(+3.15%)
After-Hours: 05:11
Altimmune EPS Diluted (Quarterly) : -0.2719 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| CorMedix, Inc. | 0.1493 |
| Amgen, Inc. | 2.455 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Viking Therapeutics, Inc. | -1.383 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.36M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 27.38M |
| Enterprise Value | 196.09M |
| Profit Margin (Quarterly) | -105.2K% |
| Earnings Yield | -30.45% |
| Normalized Earnings Yield | -30.45 |